FDA inspection
Tianjin Kingyork Pharmaceuticals Co., Ltd: FDA inspection ending Aug 27, 2019
FDA inspection 1102217 · Voluntary Action Indicated (VAI) · Tianjin
Key facts
| Inspection ID | 1102217 |
|---|---|
| Firm | Tianjin Kingyork Pharmaceuticals Co., Ltd |
| FEI number | 3013844768 |
| Address | Teda 221, Huanghai Road |
| City | Tianjin |
| Fiscal year | 2019 |
| Inspection end date | Aug 27, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data